ATIM-12. NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY PROMOTES INTRATUMORAL AND SYSTEMIC IMMUNE RESPONSES IN RECURRENT GLIOBLASTOMA: AN IVY CONSORTIUM TRIAL

Glioblastoma is the most common malignant brain tumor in adults and is associated with poor survival. It is often resistant to standard-of-care chemotherapy and radiation, necessitating the development of more effective treatments. The Ivy Foundation Early Phase Clinical Trials’ Consortium conducted...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Prins, Robert, Mochizuki, Aaron, Orpilla, Joey, Lee, Alexander, Davidson, Tom, Gaffey, Sarah, Sanders, Catherine, Rytlewski, Julie, Ellingson, Benjamin, Li, Gang, Yong, William, Clarke, Jennifer, Arrillaga-Romany, Isabel, Colman, Howard, Reardon, David, Kaley, Thomas, de Groot, John, Liau, Linda, Wen, Patrick, Cloughesy, Timothy
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216127/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados